Approval · Notice of Compliance 31059 · 2023
CINRYZE: Notice of Compliance 31059
Issued June 26, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31059
- Date
- June 26, 2023
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing site for the drug substanc.Changes to the drug substance manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CINRYZE | Not yet assigned | — |
Medicinal ingredients
- C1 ESTERASE INHIBITOR (HUMAN) 500 UNIT per VIAL